ADx NeuroSciences

Foundation date

16/09/2011

Sector

#Biotechnology - Therapeutics

Subsector

We create tailor-made antibodies and assays to quantify unique biomarkers in a wide variety of neurodegenerative diseases and conditions such as Alzheimer’s disease, Parkinson’s disease and traumatic brain injury. Our assays enable early detection before symptoms appear, providing valuable information from the drug development phase up to clinical practice, to improve the life of patients.

Upcoming events

Latest news

  • Scientists discover viral trapdoor blocking HIV and herpes

    1 day ago

  • UZ Leuven and KU Leuven invest 14 million euro in new cell and gene therapy facility

    Tuesday October 8th 2024

  • Galapagos welcomes Oleg Nodelman to its Board of Directors to support strategic growth

    Monday October 7th 2024

Jobs by ADx NeuroSciences